Workflow
未名医药:股票被实施其他风险警示 股票简称变更为“ST未名”

Group 1 - The company Wemin Pharmaceutical (002581.SZ) announced that its subsidiary Tianjin Wemin is expected to be unable to resume normal production and business activities within three months [1] - As a result, the company's stock will be subject to "other risk warnings," and the stock name will change to "ST Wemin" starting from July 8, 2025 [1] - Following the implementation of the risk warning, the daily price fluctuation limit for the company's stock will be reduced from 10% to 5% [1]